Literature DB >> 9636196

Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice.

J Xue1, Q Wu, L A Westfield, E A Tuley, D Lu, Q Zhang, K Shim, X Zheng, J E Sadler.   

Abstract

Deficiency of blood coagulation factor V or tissue factor causes the death of mouse embryos by 10.5 days of gestation, suggesting that part of the blood coagulation system is necessary for development. This function is proposed to require either generation of the serine protease thrombin and cell signaling through protease-activated receptors or an activity of tissue factor that is distinct from blood clotting. We find that murine deficiency of prothrombin clotting factor 2 (Cf2) was associated with the death of approximately 50% of Cf2(-/-) embryos by embryonic day 10.5 (E10.5), and surviving embryos had characteristic defects in yolk sac vasculature. Most of the remaining Cf2(-/-) embryos died by E15.5, but those surviving to E18.5 appeared normal. The rare Cf2(-/-) neonates died of hemorrhage on the first postnatal day. These studies suggest that a part of the blood coagulation system is adapted to perform a developmental function. Other mouse models show that the absence of platelets or of fibrinogen does not cause fetal wastage. Therefore, the role of thrombin in development may be independent of its effects on blood coagulation and instead may involve signal transduction on cells other than platelets.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636196      PMCID: PMC22696          DOI: 10.1073/pnas.95.13.7603

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Prothrombin.

Authors:  K G Mann
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

2.  A factor IX-deficient mouse model for hemophilia B gene therapy.

Authors:  L Wang; M Zoppè; T M Hackeng; J H Griffin; K F Lee; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  A molecular mechanism for synapse elimination: novel inhibition of locally generated thrombin delays synapse loss in neonatal mouse muscle.

Authors:  M N Zoubine; J Y Ma; I V Smirnova; B A Citron; B W Festoff
Journal:  Dev Biol       Date:  1996-11-01       Impact factor: 3.582

4.  Nucleotide sequence of the gene for human prothrombin.

Authors:  S J Degen; E W Davie
Journal:  Biochemistry       Date:  1987-09-22       Impact factor: 3.162

5.  Sequence of cDNA for murine Zfy-1, a candidate for Tdy.

Authors:  A Ashworth; S Swift; N Affara
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.

Authors:  E D Rosen; J C Chan; E Idusogie; F Clotman; G Vlasuk; T Luther; L R Jalbert; S Albrecht; L Zhong; A Lissens; L Schoonjans; L Moons; D Collen; F J Castellino; P Carmeliet
Journal:  Nature       Date:  1997-11-20       Impact factor: 49.962

8.  Protease-activated receptor 3 is a second thrombin receptor in humans.

Authors:  H Ishihara; A J Connolly; D Zeng; M L Kahn; Y W Zheng; C Timmons; T Tram; S R Coughlin
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

9.  Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy.

Authors:  F Forestier; F Daffos; M Rainaut; Y Solé; J Amiral
Journal:  Thromb Haemost       Date:  1985-06-24       Impact factor: 5.249

10.  Thrombin modulates and reverses neuroblastoma neurite outgrowth.

Authors:  D Gurwitz; D D Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

View more
  46 in total

Review 1.  How the protease thrombin talks to cells.

Authors:  S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Structural Architecture of Prothrombin in Solution Revealed by Single Molecule Spectroscopy.

Authors:  Nicola Pozzi; Dominika Bystranowska; Xiaobing Zuo; Enrico Di Cera
Journal:  J Biol Chem       Date:  2016-07-19       Impact factor: 5.157

3.  Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo.

Authors:  Frank M Szaba; Stephen T Smiley
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

Review 4.  Genetic sequence analysis of inherited bleeding diseases.

Authors:  Flora Peyvandi; Tom Kunicki; David Lillicrap
Journal:  Blood       Date:  2013-10-11       Impact factor: 22.113

5.  A combined deficiency of tissue factor and PAR-4 is associated with fatal pulmonary hemorrhage in mice.

Authors:  Michael F Bode; Nigel Mackman
Journal:  Thromb Res       Date:  2016-08-22       Impact factor: 3.944

6.  Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation.

Authors:  J Erlich; G C Parry; C Fearns; M Muller; P Carmeliet; T Luther; N Mackman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 7.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

8.  Microarray analysis of prothrombin knockdown in zebrafish.

Authors:  Kenneth R Day; Pudur Jagadeeswaran
Journal:  Blood Cells Mol Dis       Date:  2009-05-13       Impact factor: 3.039

9.  Reduced thrombin generation increases host susceptibility to group A streptococcal infection.

Authors:  Hongmin Sun; Xixi Wang; Jay L Degen; David Ginsburg
Journal:  Blood       Date:  2008-12-03       Impact factor: 22.113

10.  Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain.

Authors:  Eric S Mullins; Keith W Kombrinck; Kathryn E Talmage; Maureen A Shaw; David P Witte; Joni M Ullman; Sandra J Degen; William Sun; Matthew J Flick; Jay L Degen
Journal:  Blood       Date:  2008-10-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.